SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-023462
Filing Date
2024-02-05
Accepted
2024-02-05 07:36:02
Documents
20
Period of Report
2024-02-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d732838d8k.htm   iXBRL 8-K 48996
2 EX-3.1 d732838dex31.htm EX-3.1 129897
3 EX-10.1 d732838dex101.htm EX-10.1 52066
4 EX-10.2 d732838dex102.htm EX-10.2 6673
5 EX-14.1 d732838dex141.htm EX-14.1 66691
9 GRAPHIC g732838g0204113911571.jpg GRAPHIC 3643
10 GRAPHIC g732838g0204113911780.jpg GRAPHIC 22782
  Complete submission text file 0001193125-24-023462.txt   547363

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA syre-20240201.xsd EX-101.SCH 2876
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE syre-20240201_lab.xml EX-101.LAB 19501
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syre-20240201_pre.xml EX-101.PRE 12173
21 EXTRACTED XBRL INSTANCE DOCUMENT d732838d8k_htm.xml XML 3973
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 24593964
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)